CMSCX | VSGAX | CMSCX / VSGAX | |
Total Expense Ratio | 0.99 | 0.07 | 1,414% |
Annual Report Gross Expense Ratio | 1.00 | 0.07 | 1,429% |
Fund Existence | 29 years | 14 years | - |
Gain YTD | -16.690 | -15.571 | 107% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000 | 3000 | 67% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.98B | 33.7B | 6% |
Annual Yield % from dividends | 0.00 | 0.60 | - |
Returns for 1 year | -6.97 | -6.41 | 109% |
Returns for 3 years | 7.66 | 0.01 | 51,206% |
Returns for 5 years | 32.81 | 46.78 | 70% |
Returns for 10 years | -16.63 | 79.60 | -21% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
EUGAX | 24.59 | 0.47 | +1.95% |
Morgan Stanley Europe Opportunity A | |||
LAMSX | 21.23 | 0.40 | +1.92% |
Lord Abbett Dividend Growth R4 | |||
BRWAX | 21.61 | 0.40 | +1.89% |
MFS Blended Research Growth Eq A | |||
KLCIX | 16.44 | 0.29 | +1.80% |
Federated Hermes Kaufmann Large Cap IS | |||
VXTRF | 0.02 | N/A | -1.36% |
VOXTUR ANALYTICS CORP. |